author-photo

Joi Dunbar

16

Papers

571

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

NOUVEAU SCHÉMA POSOLOGIQUE

2018
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1 study to evaluate the absorption, metabolism and excretion of the NAV1.7-selective sodium channel blocker BIIB074

2018 Drug Metabolism and Pharmacokinetics
Show All
- Source
- Cite
- Save
Citations (3)
Preliminary safety and efficacy of IPI-145, a potent inhibitor of phosphoinositide-3-kinase-δ,γ, in patients with relapsed/refractory lymphoma.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (37)
a Phase 1 Evaluation of Duvelisib (IPI-145), a PI3K-δ,γ Inhibitor, in Patients with Relapsed/Refractory iNHL

2014 Blood
Show All
- Source
- Cite
- Save
Citations (46)
Preliminary Safety and Efficacy Of IPI-145, a Potent Inhibitor Of Phosphoinositide-3-Kinase-δ,γ, In Patients With Chronic Lymphocytic Leukemia

2013 Blood
Show All
- Source
- Cite
- Save
Citations (25)
Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors

2013 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (127)
The pre-clinical absorption, distribution, metabolism and excretion properties of IPI-926, an orally bioavailable antagonist of the hedgehog signal transduction pathway

2013 Xenobiotica
Show All
- Source
- Cite
- Save
Citations (4)
PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models

2013 Chemistry & Biology
Show All
- Source
- Cite
- Save
Citations (164)
A Phase I Study of the HSP90 Inhibitor Retaspimycin Hydrochloride (IPI-504) in Patients with Gastrointestinal Stromal Tumors or Soft-Tissue Sarcomas

2013 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (55)
Pharmacokinetics and Pharmacodynamics of IPI-145, a Potent Inhibitor of Phosphoinositide-3-Kinase-δ,γ, Following Single- and Multiple-Dose Administration in Healthy Subjects and Patients with Advanced Hematologic Malignancies

2012 Blood
Show All
- Source
- Cite
- Save
Citations (4)